Romatizmal Kapak Hastalığı ve Spora Katılım
Özet
Akut Romatizmal Ateş (ARA); streptokokların (ß-hemolitik Grup A) neden olduğu üst solunum yolu enfeksiyonundan ortalama 1-5 hafta sonra meydana gelen nonsüpüratif inflamatuvar tabloya denmektedir. Romatizmal kapak hastalıkları ise bir veya birden çok ARA atağı sonrasında gelişen, öncelikle kapak yetmezlikleri, ilerleyen yaşlarda kapak darlıkları ile karşımıza çıkan bir tablodur. Bu hastalara daha sağlıklı bir yaşam için spor yapmaları önerilir. Spor öncesi öykü ve fizik muayene ile değerlendirildikten sonra elektrokardiyografi, ekokardiyografi ve egzersiz testlerinin yapılması ve kılavuzların önerdiği parametrelerin detaylı bir biçimde değerlendirilmesi tavsiye edilir.
Referanslar
Tani LY. Rheumatic fever and rheumatic heart disease. In: Allen HD, Driscoll MD, Shaddy RE, Feltes TF, eds. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013.p. 1303-30.
Gewitz MH, Robert s, Tani lY, sable CA, Carapedis C, Remenyi B, et al. Revision of the jones Criteria for the Diagnosis of Acute Rheumatic Fever in the Era of Doppler Echocardiography A scientific statement From the American Heart Association. Circulation. 2015;131:1806-18.doi: 10.1161/CIR.0000000000000205.
Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientififc statement from the american heart association rheumatic fever, endocarditis and kawasai disease committee of the council on cardiovascular disease in the young, the interdisciplinary council on functional genomics and translational bilology, and the interdisciplinary council on puality of care and outcomes research. Circulation. 2009;119:1541- 51. doi: 10.1161/CIRCULATIONAHA.109.191959.
Quinn RW Did scarlet fever and rheumatic fever exist in Hippocrates' time? Rev Infect Dis. 1991;13(6):1243-4.doi: 10.1093/clinids/13.6.1243.
Carapetis JR, Currie BJ. Rheumatic fever in a high incidence population: the importance of mono arthritis and low grade fever. Arch Dis Child. 2001;85:223-7.doi: 10.1136/adc.85.3.223.
Shulman ST. T. Duckett Jones and his criteria for the diagnosis of acute rheumatic fever. Pediatr Ann. 1999;28(1):9-12. doi: 10.3928/0090-4481-19990101-04.
Carapetis jR. Mc Donald M. Wilson N. Acute rheumatic fever. Lancet. 2005;366:155-66. doi: 10.1016/S0140-6736(05)66874-2.
Mortality and Causes of Death Collaborators. 2 Global, Regional, and National age-sex specific all-cause and cause-specific mortality for 240 causes of death, Lancet. 2015;385(9963): 117-71.doi: 10.1016/S0140-6736(14)61682-2.
Eroğlu AG. Akut Romatizmal ateş tanısında güncelleme: 2015 jones ölçütleri. Turk pediatri Ars. 2016;51(1):1-7. doi: 10.5152/TurkPediatriArs.2016.2397.
Kılınç M. Romatizmal mitral kapak hastalıkları. Baysal MK, editör. Çocukluk Çağında Akut Romatizmal Ateş ve Romatizmal Kalp Hastalıkları. 1. Baskı. Ankara: Türkiye Klinikleri; 2020. p.61-8.
Saxena A. Echocardiographic diagnosis of chronic rheumatic valvular lesions. Global Heart. 2013;8(3):203-12. doi: 10.1016/j.gheart.2013.08.007.
Atalay S, Ramoğlu MG. Akut romatizmal ateşte medikal tedavi. Baysal MK, editör. Çocukluk Çağında Akut Romatizmal Ateş ve Romatizmal Kalp Hastalıkları. 1. Baskı. Ankara: Türkiye Klinikleri; 2020. p.38-41.
Yavuz T, Nisli K, Öner N, Dindar A, Aydoğan Ü, Ömeroğlu RE, et al. Long term follow up results of 139 Turkish children and adolescents with rheumatic heart disease. Eur J Pediatr. 2008;167:1321-6. doi: 10.1007/s00431-008-0799-6.
Bonow RO, Nishimura RA, Thompson PD, Udelson JE. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 5: valvular heart disease: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;66(21):2385– 92. doi: 10.1016/j.jacc.2015.09.037.
Antonio Pelliccia, Sanjay Sharma, Sabiha Gati et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease.Eur Heart J. 2021 Jan 1;42(1):17-96. doi: 10.1093/eurheartj/ehaa605.
Levine BD, Baggish AL, Kovacs RJ, Link MS, Maron MS, Mitchell JH. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 1: classification of sports: dynamic, static, and impact: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e262–6. doi: 10.1161/CIR.0000000000000237.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, et al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57–185.doi: 10.1016/j.jacc.2014.02.536. Epub 2014 Mar 3.
Pelliccia A, Culasso F, Di Paolo M, Maron BJ. Physiologic left ventricular cavity dilation in elite athletes. Ann Intern Med. 1999;130(1):23–31. doi: 10.7326/0003-4819-130-1-199901050-00005.
Antonio B. Fernandez, Paul D. Thompson. Exercise Participation for Patients with Valvular Heart Disease: a Review of the Current Guidelines. Current Cardiology Reports.2021; 23: 49. doi: 10.1007/s11886-021-01480-9.
Referanslar
Tani LY. Rheumatic fever and rheumatic heart disease. In: Allen HD, Driscoll MD, Shaddy RE, Feltes TF, eds. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013.p. 1303-30.
Gewitz MH, Robert s, Tani lY, sable CA, Carapedis C, Remenyi B, et al. Revision of the jones Criteria for the Diagnosis of Acute Rheumatic Fever in the Era of Doppler Echocardiography A scientific statement From the American Heart Association. Circulation. 2015;131:1806-18.doi: 10.1161/CIR.0000000000000205.
Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientififc statement from the american heart association rheumatic fever, endocarditis and kawasai disease committee of the council on cardiovascular disease in the young, the interdisciplinary council on functional genomics and translational bilology, and the interdisciplinary council on puality of care and outcomes research. Circulation. 2009;119:1541- 51. doi: 10.1161/CIRCULATIONAHA.109.191959.
Quinn RW Did scarlet fever and rheumatic fever exist in Hippocrates' time? Rev Infect Dis. 1991;13(6):1243-4.doi: 10.1093/clinids/13.6.1243.
Carapetis JR, Currie BJ. Rheumatic fever in a high incidence population: the importance of mono arthritis and low grade fever. Arch Dis Child. 2001;85:223-7.doi: 10.1136/adc.85.3.223.
Shulman ST. T. Duckett Jones and his criteria for the diagnosis of acute rheumatic fever. Pediatr Ann. 1999;28(1):9-12. doi: 10.3928/0090-4481-19990101-04.
Carapetis jR. Mc Donald M. Wilson N. Acute rheumatic fever. Lancet. 2005;366:155-66. doi: 10.1016/S0140-6736(05)66874-2.
Mortality and Causes of Death Collaborators. 2 Global, Regional, and National age-sex specific all-cause and cause-specific mortality for 240 causes of death, Lancet. 2015;385(9963): 117-71.doi: 10.1016/S0140-6736(14)61682-2.
Eroğlu AG. Akut Romatizmal ateş tanısında güncelleme: 2015 jones ölçütleri. Turk pediatri Ars. 2016;51(1):1-7. doi: 10.5152/TurkPediatriArs.2016.2397.
Kılınç M. Romatizmal mitral kapak hastalıkları. Baysal MK, editör. Çocukluk Çağında Akut Romatizmal Ateş ve Romatizmal Kalp Hastalıkları. 1. Baskı. Ankara: Türkiye Klinikleri; 2020. p.61-8.
Saxena A. Echocardiographic diagnosis of chronic rheumatic valvular lesions. Global Heart. 2013;8(3):203-12. doi: 10.1016/j.gheart.2013.08.007.
Atalay S, Ramoğlu MG. Akut romatizmal ateşte medikal tedavi. Baysal MK, editör. Çocukluk Çağında Akut Romatizmal Ateş ve Romatizmal Kalp Hastalıkları. 1. Baskı. Ankara: Türkiye Klinikleri; 2020. p.38-41.
Yavuz T, Nisli K, Öner N, Dindar A, Aydoğan Ü, Ömeroğlu RE, et al. Long term follow up results of 139 Turkish children and adolescents with rheumatic heart disease. Eur J Pediatr. 2008;167:1321-6. doi: 10.1007/s00431-008-0799-6.
Bonow RO, Nishimura RA, Thompson PD, Udelson JE. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 5: valvular heart disease: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;66(21):2385– 92. doi: 10.1016/j.jacc.2015.09.037.
Antonio Pelliccia, Sanjay Sharma, Sabiha Gati et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease.Eur Heart J. 2021 Jan 1;42(1):17-96. doi: 10.1093/eurheartj/ehaa605.
Levine BD, Baggish AL, Kovacs RJ, Link MS, Maron MS, Mitchell JH. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 1: classification of sports: dynamic, static, and impact: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e262–6. doi: 10.1161/CIR.0000000000000237.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, et al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57–185.doi: 10.1016/j.jacc.2014.02.536. Epub 2014 Mar 3.
Pelliccia A, Culasso F, Di Paolo M, Maron BJ. Physiologic left ventricular cavity dilation in elite athletes. Ann Intern Med. 1999;130(1):23–31. doi: 10.7326/0003-4819-130-1-199901050-00005.
Antonio B. Fernandez, Paul D. Thompson. Exercise Participation for Patients with Valvular Heart Disease: a Review of the Current Guidelines. Current Cardiology Reports.2021; 23: 49. doi: 10.1007/s11886-021-01480-9.
